1. Home
  2. EVER vs NUVB Comparison

EVER vs NUVB Comparison

Compare EVER & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVER
  • NUVB
  • Stock Information
  • Founded
  • EVER 2008
  • NUVB 2018
  • Country
  • EVER United States
  • NUVB United States
  • Employees
  • EVER N/A
  • NUVB N/A
  • Industry
  • EVER Computer Software: Programming Data Processing
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVER Technology
  • NUVB Health Care
  • Exchange
  • EVER Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • EVER 929.6M
  • NUVB 837.0M
  • IPO Year
  • EVER 2018
  • NUVB N/A
  • Fundamental
  • Price
  • EVER $23.38
  • NUVB $2.91
  • Analyst Decision
  • EVER Strong Buy
  • NUVB Strong Buy
  • Analyst Count
  • EVER 5
  • NUVB 6
  • Target Price
  • EVER $32.40
  • NUVB $8.00
  • AVG Volume (30 Days)
  • EVER 534.3K
  • NUVB 4.7M
  • Earning Date
  • EVER 08-04-2025
  • NUVB 08-07-2025
  • Dividend Yield
  • EVER N/A
  • NUVB N/A
  • EPS Growth
  • EVER N/A
  • NUVB N/A
  • EPS
  • EVER 1.24
  • NUVB N/A
  • Revenue
  • EVER $615,246,000.00
  • NUVB $14,355,000.00
  • Revenue This Year
  • EVER $32.07
  • NUVB $332.80
  • Revenue Next Year
  • EVER $11.08
  • NUVB $360.12
  • P/E Ratio
  • EVER $18.83
  • NUVB N/A
  • Revenue Growth
  • EVER 92.92
  • NUVB 900.35
  • 52 Week Low
  • EVER $16.63
  • NUVB $1.54
  • 52 Week High
  • EVER $30.03
  • NUVB $3.46
  • Technical
  • Relative Strength Index (RSI)
  • EVER 45.47
  • NUVB 66.89
  • Support Level
  • EVER $22.37
  • NUVB $2.57
  • Resistance Level
  • EVER $23.99
  • NUVB $2.55
  • Average True Range (ATR)
  • EVER 1.03
  • NUVB 0.20
  • MACD
  • EVER -0.11
  • NUVB 0.03
  • Stochastic Oscillator
  • EVER 34.88
  • NUVB 90.62

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: